{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:15:12Z","timestamp":1793981712546,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873748"],"award-info":[{"award-number":["81873748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971193"],"award-info":[{"award-number":["81971193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571171"],"award-info":[{"award-number":["81571171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH254"],"award-info":[{"award-number":["ZR2023MH254"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inflammatory response triggered by innate immunity plays a pivotal element in the progress of ischemic stroke. Receptor-interacting kinase 2 (RIP2) is implicated in maintaining immunity homeostasis and regulating inflammatory response. However, the underlying mechanism of RIP2 in ischemic stroke is still not well\u00a0understood. Hence, the study investigated the role and the ubiquitination regulatory mechanism of RIP2 in ischemic stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Focal cerebral ischemia was introduced by middle cerebral artery occlusion (MCAO) in wild-type (WT) and OTUD1-deficient (OTUD1<jats:sup>\u2212\/\u2212<\/jats:sup>) mice, oxygen glucose deprivation and reoxygenation (OGD\/R) models in BV2 cells and primary cultured astrocytes were performed for monitoring of experimental stroke. GSK2983559 (GSK559), a RIP2 inhibitor was intraventricularly administered 30\u00a0min before MCAO. Mice brain tissues were collected for TTC staining and histopathology. Protein expression of RIP2, OTUD1, p-NF-\u03baB\u2013p65 and I\u03baB\u03b1 was determined by western blot. Localization of RIP2 and OTUD1 was examined by immunofluorescence. The change of IL-1\u03b2, IL-6 and TNF-\u03b1 was detected by ELISA assay and quantitative real-time polymerase chain reaction. Immunoprecipitation and confocal microscopy were used to study the interaction of RIP2 and OTUD1. The activity of NF-\u03baB was examined by dual-luciferase assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results showed upregulated protein levels of RIP2 and OTUD1 in microglia and astrocytes in mice subjected to focal cerebral ischemia. Inhibition of RIP2 by GSK559 ameliorated the cerebral ischemic outcome by repressing the NF-\u03baB activity and the inflammatory response. Mechanistically, OTUD1 interacted with RIP2 and sequentially removed the K63-linked polyubiquitin chains of RIP2, thereby inhibiting NF-\u03baB activation. Furthermore, OTUD1 deficiency exacerbated cerebral ischemic injury in response to inflammation induced by RIP2 ubiquitination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings suggested that RIP2 mediated cerebral ischemic lesion via stimulating inflammatory response, and OTUD1 ameliorated brain injury after ischemia through inhibiting RIP2-induced NF-\u03baB activation by specifically cleaving K63-linked ubiquitination of RIP2.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02968-7","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T11:02:47Z","timestamp":1701082967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["OTUD1 ameliorates cerebral ischemic injury through inhibiting inflammation by disrupting K63-linked deubiquitination of RIP2"],"prefix":"10.1186","volume":"20","author":[{"given":"Shengnan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"2968_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(16)30962-X","volume":"389","author":"GJ Hankey","year":"2017","unstructured":"Hankey GJ. Stroke. Lancet. 2017;389:641\u201354.","journal-title":"Lancet"},{"key":"2968_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1747493019832996","volume":"14","author":"VL Feigin","year":"2019","unstructured":"Feigin VL. Anthology of stroke epidemiology in the 20th and 21st centuries: assessing the past, the present, and envisioning the future. Int J Stroke. 2019;14:223\u201337.","journal-title":"Int J Stroke"},{"key":"2968_CR3","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.3390\/ijms21186454","volume":"21","author":"CD Maida","year":"2020","unstructured":"Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21:6454.","journal-title":"Int J Mol Sci"},{"key":"2968_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBDS Collaborators","year":"2021","unstructured":"Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"2968_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S1474-4422(18)30323-5","volume":"17","author":"AM Thiebaut","year":"2018","unstructured":"Thiebaut AM, Gauberti M, Ali C, Martinez de Lizarrondo S, Vivien D, Yepes M, Roussel BD. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. Lancet Neurol. 2018;17:1121\u201332.","journal-title":"Lancet Neurol"},{"key":"2968_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","volume":"128","author":"K Shi","year":"2021","unstructured":"Shi K, Zou M, Jia DM, Shi S, Yang X, Liu Q, Dong JF, Sheth KN, Wang X, Shi FD. tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke. Circ Res. 2021;128:62\u201375.","journal-title":"Circ Res"},{"key":"2968_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7150\/ijbs.10927","volume":"11","author":"H Liu","year":"2015","unstructured":"Liu H, Wei X, Kong L, Liu X, Cheng L, Yan S, Zhang X, Chen L. NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species. Int J Biol Sci. 2015;11:525\u201335.","journal-title":"Int J Biol Sci"},{"key":"2968_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molmed.2017.11.002","volume":"24","author":"A Annibaldi","year":"2018","unstructured":"Annibaldi A, Meier P. Checkpoints in TNF-induced cell death: implications in inflammation and cancer. Trends Mol Med. 2018;24:49\u201365.","journal-title":"Trends Mol Med"},{"key":"2968_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.molcel.2013.06.004","volume":"50","author":"BK Fiil","year":"2013","unstructured":"Fiil BK, Damgaard RB, Wagner SA, Keusekotten K, Fritsch M, Bekker-Jensen S, Mailand N, Choudhary C, Komander D, Gyrd-Hansen M. OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell. 2013;50:818\u201330.","journal-title":"Mol Cell"},{"key":"2968_CR10","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.celrep.2015.11.009","volume":"13","author":"P Draber","year":"2015","unstructured":"Draber P, Kupka S, Reichert M, Draberova H, Lafont E, de Miguel D, Spilgies L, Surinova S, Taraborrelli L, Hartwig T, et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 2015;13:2258\u201372.","journal-title":"Cell Rep"},{"key":"2968_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/cdd.2017.33","volume":"24","author":"A Witt","year":"2017","unstructured":"Witt A, Vucic D. Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling. Cell Death Differ. 2017;24:1160\u201371.","journal-title":"Cell Death Differ"},{"key":"2968_CR12","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1038\/s41467-018-07016-0","volume":"9","author":"S Panda","year":"2018","unstructured":"Panda S, Gekara NO. The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex. Nat Commun. 2018;9:4654.","journal-title":"Nat Commun"},{"key":"2968_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2968_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","volume":"154","author":"TE Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, et al. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell. 2013;154:169\u201384.","journal-title":"Cell"},{"key":"2968_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellsig.2017.02.011","volume":"33","author":"S Piao","year":"2017","unstructured":"Piao S, Pei HZ, Huang B, Baek SH. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53. Cell Signal. 2017;33:22\u20139.","journal-title":"Cell Signal"},{"key":"2968_CR16","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","volume":"9","author":"F Yao","year":"2018","unstructured":"Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, Chang L, Liu N, Zeng L, Wang W, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9:2269.","journal-title":"Nat Commun"},{"key":"2968_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaut.2018.07.019","volume":"94","author":"D Lu","year":"2018","unstructured":"Lu D, Song J, Sun Y, Qi F, Liu L, Jin Y, McNutt MA, Yin Y. Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders. J Autoimmun. 2018;94:156\u201365.","journal-title":"J Autoimmun"},{"key":"2968_CR18","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.4049\/jimmunol.2001253","volume":"206","author":"X Chen","year":"2021","unstructured":"Chen X, Zhang H, Wang X, Shao Z, Li Y, Zhao G, Liu F, Liu B, Zheng Y, Chen T, et al. OTUD1 regulates antifungal innate immunity through deubiquitination of CARD9. J Immunol. 2021;206:1832\u201343.","journal-title":"J Immunol"},{"key":"2968_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102058","volume":"45","author":"S Zeng","year":"2021","unstructured":"Zeng S, Zhao Z, Zheng S, Wu M, Song X, Li Y, Zheng Y, Liu B, Chen L, Gao C, Liu H. The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR. Redox Biol. 2021;45: 102058.","journal-title":"Redox Biol"},{"key":"2968_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbi.2020.04.016","volume":"88","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Sun Y, He Z, Xu Y, Li X, Ding J, Lu M, Hu G. Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression. Brain Behav Immun. 2020;88:471\u201381.","journal-title":"Brain Behav Immun"},{"key":"2968_CR21","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1111\/jcmm.14223","volume":"23","author":"L Chen","year":"2019","unstructured":"Chen L, Kong L, Wei X, Wang Y, Wang B, Zhang X, Sun J, Liu H. beta-arrestin 2 negatively regulates NOD2 signalling pathway through association with TRAF6 in microglia after cerebral ischaemia\/reperfusion injury. J Cell Mol Med. 2019;23:3325\u201335.","journal-title":"J Cell Mol Med"},{"key":"2968_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2005.05.069","volume":"386","author":"X Wei","year":"2005","unstructured":"Wei X, Liu H, Sun X, Fu F, Zhang X, Wang J, An J, Ding H. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci Lett. 2005;386:58\u201362.","journal-title":"Neurosci Lett"},{"key":"2968_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2017.08.028","volume":"815","author":"L Chen","year":"2017","unstructured":"Chen L, Ren Z, Wei X, Wang S, Wang Y, Cheng Y, Gao H, Liu H. Losartan protects against cerebral ischemia\/reperfusion-induced apoptosis through beta-arrestin1-mediated phosphorylation of Akt. Eur J Pharmacol. 2017;815:98\u2013108.","journal-title":"Eur J Pharmacol"},{"key":"2968_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12974-018-1289-z","volume":"15","author":"L Cheng","year":"2018","unstructured":"Cheng L, Chen L, Wei X, Wang Y, Ren Z, Zeng S, Zhang X, Wen H, Gao C, Liu H. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson\u2019s disease. J Neuroinflammation. 2018;15:243.","journal-title":"J Neuroinflammation"},{"key":"2968_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.650403","volume":"12","author":"H Honjo","year":"2021","unstructured":"Honjo H, Watanabe T, Kamata K, Minaga K, Kudo M. RIPK2 as a new therapeutic target in inflammatory bowel diseases. Front Pharmacol. 2021;12: 650403.","journal-title":"Front Pharmacol"},{"key":"2968_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899372","volume":"37","author":"M Hrdinka","year":"2018","unstructured":"Hrdinka M, Schlicher L, Dai B, Pinkas DM, Bufton JC, Picaud S, Ward JA, Rogers C, Suebsuwong C, Nikhar S, et al. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. EMBO J. 2018;37: e99372.","journal-title":"EMBO J"},{"key":"2968_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2016.07.019","volume":"166","author":"RB Damgaard","year":"2016","unstructured":"Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, McHale D, Maher ER, McKenzie ANJ, Komander D. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell. 2016;166:1215.","journal-title":"Cell"},{"key":"2968_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2010.12.015","volume":"34","author":"PJ Shaw","year":"2011","unstructured":"Shaw PJ, Barr MJ, Lukens JR, McGargill MA, Chi H, Mak TW, Kanneganti TD. Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity. 2011;34:75\u201384.","journal-title":"Immunity"},{"key":"2968_CR29","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1038\/ncomms7442","volume":"6","author":"U Nachbur","year":"2015","unstructured":"Nachbur U, Stafford CA, Bankovacki A, Zhan Y, Lindqvist LM, Fiil BK, Khakham Y, Ko HJ, Sandow JJ, Falk H, et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat Commun. 2015;6:6442.","journal-title":"Nat Commun"},{"key":"2968_CR30","doi-asserted-by":"publisher","first-page":"29651","DOI":"10.1074\/jbc.M114.591388","volume":"289","author":"JT Tigno-Aranjuez","year":"2014","unstructured":"Tigno-Aranjuez JT, Benderitter P, Rombouts F, Deroose F, Bai X, Mattioli B, Cominelli F, Pizarro TT, Hoflack J, Abbott DW. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem. 2014;289:29651\u201364.","journal-title":"J Biol Chem"},{"key":"2968_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/416194a","volume":"416","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA. RICK\/Rip2\/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194\u20139.","journal-title":"Nature"},{"key":"2968_CR32","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1073\/pnas.2534856100","volume":"100","author":"WH Zhang","year":"2003","unstructured":"Zhang WH, Wang X, Narayanan M, Zhang Y, Huo C, Reed JC, Friedlander RM. Fundamental role of the Rip2\/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc Natl Acad Sci U S A. 2003;100:16012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2968_CR33","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/s41467-017-02029-7","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Fan Y, Xie F, Zhou H, Jin K, Shao L, Shi W, Fang P, Yang B, van Dam H, et al. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nat Commun. 2017;8:2116.","journal-title":"Nat Commun"},{"key":"2968_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051162","volume":"22","author":"J Song","year":"2021","unstructured":"Song J, Liu T, Yin Y, Zhao W, Lin Z, Yin Y, Lu D, You F. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep. 2021;22: e51162.","journal-title":"EMBO Rep"},{"key":"2968_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007067","volume":"14","author":"L Zhang","year":"2018","unstructured":"Zhang L, Liu J, Qian L, Feng Q, Wang X, Yuan Y, Zuo Y, Cheng Q, Miao Y, Guo T, et al. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS\/TRAF3\/TRAF6 signalosome. PLoS Pathog. 2018;14: e1007067.","journal-title":"PLoS Pathog"},{"key":"2968_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41423-021-00810-9","volume":"19","author":"B Wu","year":"2022","unstructured":"Wu B, Qiang L, Zhang Y, Fu Y, Zhao M, Lei Z, Lu Z, Wei YG, Dai H, Ge Y, et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-kappaB signaling. Cell Mol Immunol. 2022;19:276\u201389.","journal-title":"Cell Mol Immunol"},{"key":"2968_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molcel.2012.04.014","volume":"46","author":"RB Damgaard","year":"2012","unstructured":"Damgaard RB, Nachbur U, Yabal M, Wong WW, Fiil BK, Kastirr M, Rieser E, Rickard JA, Bankovacki A, Peschel C, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012;46:746\u201358.","journal-title":"Mol Cell"},{"key":"2968_CR38","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.0907131106","volume":"106","author":"A Krieg","year":"2009","unstructured":"Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, Knoefel WT, Reed JC. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106:14524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2968_CR39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cub.2009.06.038","volume":"19","author":"M Tao","year":"2009","unstructured":"Tao M, Scacheri PC, Marinis JM, Harhaj EW, Matesic LE, Abbott DW. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr Biol. 2009;19:1255\u201363.","journal-title":"Curr Biol"},{"key":"2968_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2008.02.002","volume":"28","author":"O Hitotsumatsu","year":"2008","unstructured":"Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE, Lee BL, Shiffin N, Advincula R, Malynn BA, et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity. 2008;28:381\u201390.","journal-title":"Immunity"},{"key":"2968_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcdb.2020.07.001","volume":"109","author":"Y Topal","year":"2021","unstructured":"Topal Y, Gyrd-Hansen M. RIPK2 NODs to XIAP and IBD. Semin Cell Dev Biol. 2021;109:144\u201350.","journal-title":"Semin Cell Dev Biol"},{"key":"2968_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fcell.2019.00208","volume":"7","author":"VJ Heim","year":"2019","unstructured":"Heim VJ, Stafford CA, Nachbur U. NOD signaling and cell death. Front Cell Dev Biol. 2019;7:208.","journal-title":"Front Cell Dev Biol"},{"key":"2968_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.it.2006.09.003","volume":"27","author":"A Wullaert","year":"2006","unstructured":"Wullaert A, Heyninck K, Janssens S, Beyaert R. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors. Trends Immunol. 2006;27:533\u201340.","journal-title":"Trends Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02968-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02968-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02968-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:04:52Z","timestamp":1701086692000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02968-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2968"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02968-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were in accordance with the Guidelines on the Care and Use of Laboratory Animals (National Institutes of Health Publication no. 85\u201323, revised 1996) and were approved by the Ethics Committee of Shandong University (No. ECSBMSSDU2021-2-119).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}